<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Salvia miltiorrhiza and <z:chebi fb="5" ids="18154">polysaccharide</z:chebi> <z:chebi fb="100" ids="16189">sulphate</z:chebi> are commonly prescribed for curing cerebral <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we found that the <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> of erythrocytes of the patients with <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> to cultured human umbilical vein endothelial cells was decreased in number and intensity after the erythrocytes were treated with salvia miltiorrhiza and <z:chebi fb="5" ids="18154">polysaccharide</z:chebi> <z:chebi fb="100" ids="16189">sulphate</z:chebi> in flow field </plain></SENT>
<SENT sid="2" pm="."><plain>Moreover we found that <z:chebi fb="5" ids="18154">polysaccharide</z:chebi> <z:chebi fb="100" ids="16189">sulphate</z:chebi> was more effective than salvia miltiorrhiza in preventing adherence in common doses </plain></SENT>
<SENT sid="3" pm="."><plain>The two drugs' effects of preventing adherence might be an important mechanism for curing the patients with <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> </plain></SENT>
</text></document>